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Objectives: To discuss the clinical rules of TCM four diagnostic information and
relevant indicators in qi-deﬁciency-blood-stasis syndrome of congestive heart failure,
and consummate diagnosis criteria of the syndrome.
Methods: (1) Based on databases of CNKI (1980-2012) and VIP (1989-2012), related
modern literatures on CHF were reorganized and analyzed, and syndrome factors were
extracted from them. The pathogenesis and common syndromes of this disease got
analysized. (2) 1694 CHF cases from grade 3 and ﬁrst-class hospitals (from Dec, 2010
to Sep, 2012) were collected, with rank sum test, Spearman rank correlation analysis
and factor analysis by SPSS18.0. The correlations in qi-deﬁciency-blood-stasis syn-
dromes and age, sex, primary illnesses, lab index, major and minor symptoms had
been studied. (3) 750 CHF cases from multicenter (from Dec, 2012 to Dec, 2013) were
collected by applying TCM syndrome scale of congestive heart failure. The threshold
values in clinic diagnosis of qi-deﬁciency-blood-stasis syndrome got determined by
applying maximum likelihood method combined with ROC curve. The manifestations
of tongue and pulse got analysized by logistic regression. Reference range of BNP
also got described by the mean value and median.
Results: (1) Literature analysis indicates: Syndrome factors on disease location of
CHF are the heart, kidney, lung, and the spleen. Factors on natures of this disease
sorted from more to less is qi deﬁciency, blood stasis, yang deﬁciency, yin deﬁciency,
yang exhausted, water retention, etc. The pathogenesis of CHF mainly is deﬁciency
complicated with excess, and qi-deﬁciency-blood-stasis syndrome is the common
pattern of this disease. (2) Retrospective analysis of clinical cases indicates: There are
367 cases of qi-deﬁciency-blood-stasis syndrome in 1694 CHF cases. It mostly can be
seen in male patients aged 50-70 and female patients aged over 70 years old. The
primary disease mainly is coronary heart disease. And it also has correlation with
BNP. The major symptoms of it are chest suppression, palpitation, short breath, dark-
red tongue, white fur and thin pulse. The minor one is thin fur. (3) Syndrome scale
analysis showed: The diagnosis criteria of CHF qi-deﬁciency-blood-stasis syndrome is
total score of related items is equal or greater than 76 points (sensitivity: 96.9%,
speciﬁcity: 86.9%). The results of retrospective and prospective clinical assess showed
the sensitivity and speciﬁcity was above 90%. The common manifestations of tongue
and pulse are purple tongue with petechia and uneven pulse. And the reference range
of BNP is from 209.33 to 316.57 pg/ml.
Conclusions: The essential syndrome of congestive heart failure is qi-deﬁciency
-blood-stasis syndrome. The clinical distribution links to patients’ age and gender.
Congestive heart failure mostly develops from coronary heart disease. The syndrome
scale of CHF has higher sensitivity and speciﬁcity, which is available to the clinical
application.
GW25-e0878
Decreased plasma relaxin-3 levels in patients with chronic heart failure
Zhang Xiaohui, Yin Xinhua
The Department of Cardiology, The First Afﬁliated Hospital of Harbin Medical
University, Harbin, China
Objectives: Relaxin-3 has been found to alleviate isoproterenol-induced myocardial
ischemia injury and have anti-ﬁbrotic action. The role of endogenous relaxin-3 on
chronic heart failure (CHF), however, remains unknown.
Methods: We investigated the levels of plasma relaxin-3 and their relationship to
cardiovascular function in patients with CHF. We studied 31 patients who were
admitted with CHF that was caused by left ventricular systolic dysfunction [New York
Heart Association (NYHA) functional class III or IV] and 38 age-matched healthy
subjects. Blood samples were taken at study entry, and the relaxin-3, relaxin-2 and N-
terminal pro-brain natriuretic peptide (NT-pro BNP) were measured. Cardiac structure
and function were measured by echocardiography.
Results: Relaxin-3 levels were signiﬁcantly lower in CHF patients than in controls:
the median plasma relaxin-3 concentration was 57.41 pg/ml (range, <49.56-64.42 pg/
ml) in patients with CHF and 69.37 pg/ml (range, <63.90-72.97 pg/ml) in controls
(P<0.001). However, no differences in relaxin-2 levels were observed between the
CHF group and controls (P¼0.505). The plasma levels of relaxin-3 positively
correlated with total cholesterol (r¼0.39, P¼0.032) and NT-pro BNP (r¼0.39,
P¼0.032) in patients with CHF. Plasma relaxin-3 concentration showed no statisti-
cally signiﬁcant associations with other component traits in patients with CHF.
Additionally, there was no correlation between the plasma concentrations of relaxin-3
and relaxin-2 in patients with CHF (r¼-0.25; P¼0.174).
Conclusions: We conclude that plasma relaxin-3 concentrations are decreased in
CHF, though low endogenous relaxin-3 levels are only related to total cholesterol and
NT-pro BNP.
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Objectives: Biological markers such as BNP and NT-proBNP have been widely used
in evaluation of the incidence and severity of heart failure clinically. However,
multiple mechanisms are involved in the pathophysiology process of heart failure,
thus, a single marker may not be sufﬁcient. Combination of several biological markers
may be more reliable. Galectin-3 is a new biological marker, which may participate inJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cthe regulation of cardiac ﬁbrosis and remodling. Therefore, it can be used in evalu-
ation of the incidence and severity of HF, it can also be used to predict prognosis in
patients with HF. In this study comparison of the level of serum galectin-3 in CHF and
Control, correlation analysis between the level of serum galectin-3 and LA, LVD,
LVEF and BNP in chronic heart failure were invested. Analyse and discuss the sig-
niﬁcance of serum galectin-3 in chronic heart failure. And compare of the diagnositic
value of Galectin-3 and BNP for CHF in both the sensitivity and speciﬁcity.
Methods: Patients with chronic heart failure were recruited. The signiﬁcance of heart
failure was determined by NYHA classiﬁcation II-IV. The level of serum galectin-3
was determined by sandwich ELISA. Echocardiography was performed to determine
the diastolic left atrial diameter (LA), left ventricular end-diastolic diameter (LVD)
and left ventricular ejection fraction (LVEF). Data were analyzed by SPSS 17.0,
P<0.05 was considered statistically signiﬁcant. Association of two sets of data was
evaluated with Pearson correlation analysis. Receiver-operating characteristic (ROC)
curve was used to analyze the prognostic value of galectin-3 or BNP for CHF.
Results: The level of serum galectin-3 was signiﬁcantly higher in the CHF group
compared with that in control; The differences of the level of serum galectin-3 be-
tween diffrernt sub-groups was statistically signiﬁcant (P<0.05 and P<0.01). The
level of serum galectin-3 was positively correlated with LA (r¼0.465, P<0.01) and
LVD (r¼0.643, P<0.01), but negatively correlated with LVEF (r¼-0.788, P<0.01).
The level of plasma BNP was positively correlated with LA (r¼0.464, P<0.01) and
LVD (r¼0.633, P<0.01), but negatively correlated with LVEF (r¼-0.799, P<0.01).
The level of serum galectin-3 was positively correlated with the level of plasma BNP
(r¼0.855, P<0.01). AUC was 0.808 when the level of serum galectin-3 was more than
8.61 ng/ml. The sensitivity to predict CHF was 77.1%, the speciﬁcity was 92.3%.
AUC was 0.903 when the level of plasma BNP was more than 1011 pg/ml. The
sensitivity to predict CHF was 81.6% and the speciﬁcity was 90.3%.
Conclusions: (1) The level of serum galectin-3 is related to the changes of left heart
structure and function, indicating that galectin-3 may be involved in the process of left
ventricular remodeling in CHF. (2) The speciﬁcity of galectin-3 is higher than BNP in
predicting CHF, not the sensitivity.
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Objectives: To explore the inﬂuence of individualized rehabilitation guidance for
improving heart function in patients with heart failure after myocardial infarction.
Methods: Enroll 106 hospitalized patients with heart failure after myocardial
infarction in the study, 52 male, 54 female, aging from 68 to 75, cardiac function
ranging from II to III levels. they all suffered from heart failure after myocardial
infarction and were treated with strong heart diuresis therapy. All 106 cases were
randomly divided into two groups (control group and vs. observation group), there
was no statistically signiﬁcant difference between them. Patients in control group were
treated with routine nursing care during hospital stay, while for patients in the
observation group, In addition to routine nursing instruction, individualized rehabil-
itation guidance was performed, including the rest and activity guidance, diet guid-
ance, defecation guidance, medication guidance, psychological guidance, guidance of
disease knowledge, and self-monitoring, et al. A 6 months follow-up was conducted
after discharge. The monitoring indicators including 6 minutes walking dis-
tance, B-type natriuretic peptide. heart function in hospital and 6 months after
hospitalization.
Results: 6 minutes walking distance in observation group increased signiﬁcantly than
the control group, the difference was statistically signiﬁcant (P<0.05). The level of
B-type natriuretic peptide decreased in 49 cases in the observation group, and in the
control group that was 42, the differences was statistically signiﬁcant (P<0.05).
Conclusions: Individualized inpatient rehabilitation guidance can help the patients
build up a good way of life, ensure the treatment effect, improve the patient’s heart
function and life quality.
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Objectives: To explore change and clinical signiﬁcance of the level of plasma ho-
mocysteine (HCY) in patients with dilated cardiomyopathy (DCM).
Methods: All subjects consisted of 116 consecutively hospitalized patients with
DCM, including 92 male patients and 24 female patients, aged from 18 to 70 years
old, whose average age was (47.412.7) years old and 30 age and sex matched pa-
tients with paroxysmal supraventricular tachycardia (non-attack period, without
structural heart disease) as controls. Electrocardiogram, chest X-ray and echocardi-
ography were routinely performed, as well as thyroid function and biochemical tests,
and coronary arteriongraphy when necessary. DCM is still a diagnosis by exclusion of
hypertension, coronary heart disease, rheumatic heart disease, congenital heart dis-
ease, diabetes mellitus, arteriosclerosis, etc. Blood samples were obtained to determineardiovascular Disease Clinical Research C187
